Assessment of administration routes and sequencing for a common antioxidant therapy in diabetic neuropathy, using a Bayesian network meta-analysis.
Key Takeaways
- Intravenous ALA ranked best for rapid symptom and overall objective improvement
- Oral ALA uniquely showed robust evidence for distal structural repair with I2=0%
- Sequential therapy's apparent superiority disappeared after bias sensitivity analyses